For: | Ray G. Management of liver diseases: Current perspectives. World J Gastroenterol 2022; 28(40): 5818-5826 [PMID: 36353204 DOI: 10.3748/wjg.v28.i40.5818] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i40/5818.htm |
Number | Citing Articles |
1 |
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva. Old age as a risk factor for liver diseases: Modern therapeutic approaches. Experimental Gerontology 2023; 184: 112334 doi: 10.1016/j.exger.2023.112334
|
2 |
Li-jiao Sun, Xin Chen, Sai Zhu, Jin-jin Xu, Xiao-feng Li, Shao-xi Diao, Ying-li Yang, Jin-yu Liu, Jia-nan Wang, Ying-yin Sun, Cheng Huang, Xiao-ming Meng, Hua Wang, Xiong-wen Lv, Jun Li. Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2. Acta Pharmacologica Sinica 2023; doi: 10.1038/s41401-023-01171-x
|
3 |
F. V. Hladkykh, I. V. Bielochkina, I. V. Koshurba, M. O. Chyzh. Modern hepatoprotection: a narrative review of existing approaches and prospects for the use of biotechnological drugs. Modern medical technology 2023; (3): 58 doi: 10.34287/MMT.3(58).2023.9
|
4 |
Darya Pon`kina, Sergey Kuranov, Mikhail Khvostov, Nataliya Zhukova, Yulia Meshkova, Mariya Marenina, Olga Luzina, Tatyana Tolstikova, Nariman Salakhutdinov. Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine. Molecules 2023; 28(1): 396 doi: 10.3390/molecules28010396
|